| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Karimi G | |
| Razavi BM | |||
| P2860 | cites work | Cisplatin nephrotoxicity and protection by milk thistle extract in rats | Q24816659 |
| Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection | Q27490911 | ||
| Regulation of BAD protein by PKA, PKCdelta and phosphatases in adult rat cardiac myocytes subjected to oxidative stress | Q28584319 | ||
| Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment | Q33740236 | ||
| Milk thistle: Silybum marianum. | Q33873836 | ||
| Cytoplasmic signaling pathways that regulate cardiac hypertrophy | Q34142151 | ||
| "Silymarin", a promising pharmacological agent for treatment of diseases | Q34649335 | ||
| Epigallocatechin gallate potentially attenuates Fluoride induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats | Q85677638 | ||
| Adriamycin. A new anticancer drug with significant clinical activity | Q34699440 | ||
| Silybin and silymarin--new effects and applications | Q36260585 | ||
| Arsenic exposure and cardiovascular disease: an updated systematic review | Q36354209 | ||
| Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats. | Q36608433 | ||
| Role of oxidative stress in cardiac hypertrophy and remodeling | Q36693221 | ||
| Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease | Q36711434 | ||
| Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets | Q36732005 | ||
| An updated systematic review of the pharmacology of silymarin | Q36803680 | ||
| Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads. | Q36989714 | ||
| Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid | Q37057917 | ||
| Acrolein health effects | Q37333260 | ||
| Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy | Q37624003 | ||
| Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies | Q37741316 | ||
| Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies | Q38102433 | ||
| Arsenic cardiotoxicity: An overview | Q38647497 | ||
| Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms. | Q39311021 | ||
| Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells | Q39868832 | ||
| Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model | Q41808673 | ||
| Comparison of the prophylactic effect of silymarin and deferoxamine on iron overload-induced hepatotoxicity in rat. | Q41917521 | ||
| Effects of chronic fluorosis on electrocardiogram in sheep. | Q42035919 | ||
| Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice | Q42527938 | ||
| Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway | Q42539418 | ||
| Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats | Q42709263 | ||
| Inflammatory responses induced by fluoride and arsenic at toxic concentration in rabbit aorta | Q42720473 | ||
| Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies. | Q42842353 | ||
| Silybin, a new iron-chelating agent. | Q43643233 | ||
| Influence of silymarin and its flavonolignans on doxorubicin-iron induced lipid peroxidation in rat heart microsomes and mitochondria in comparison with quercetin | Q43947614 | ||
| Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats | Q44702417 | ||
| Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans | Q44800197 | ||
| Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. | Q44957077 | ||
| Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. | Q44994665 | ||
| Iron-induced cardiac damage: role of apoptosis and deferasirox intervention | Q45300125 | ||
| Terminalia arjuna protects mouse hearts against sodium fluoride-induced oxidative stress | Q46215919 | ||
| The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine | Q46488883 | ||
| Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats | Q46590095 | ||
| Silibinin protects rat cardiac myocyte from isoproterenol-induced DNA damage independent on regulation of cell cycle. | Q53601956 | ||
| A review of plants used in the treatment of liver disease: part 1 | Q77690751 | ||
| Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1 | Q79434573 | ||
| Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent | Q80345291 | ||
| Silymarin, the antioxidant component of Silybum marianum, protects against burn-induced oxidative skin injury | Q80374958 | ||
| Effect of silymarin administration on TNF‐α serum concentration in peritoneal dialysis patients | Q82216280 | ||
| Protective effects of silymarin against doxorubicin-induced toxicity | Q83414166 | ||
| Effect of silymarin on sodium fluoride-induced toxicity and oxidative stress in rat cardiac tissues | Q84958051 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 916-923 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Iranian Journal of Basic Medical Sciences | Q20850646 |
| P1476 | title | Protective effect of silymarin against chemical-induced cardiotoxicity | |
| P478 | volume | 19 |
| Q47116620 | Acacia hydaspica ethyl acetate extract protects against cisplatin-induced DNA damage, oxidative stress and testicular injuries in adult male rats |
| Q97883804 | Clerodendrum volubile Ethanol Leaf Extract: A Potential Antidote to Doxorubicin-Induced Cardiotoxicity in Rats |
| Q94562669 | Effects of silibinin on hepatic warm ischemia-reperfusion injury in the rat model |
| Q92131748 | Evaluating the protective potency of Acacia hydaspica R. Parker on histological and biochemical changes induced by Cisplatin in the cardiac tissue of rats |
| Q46304110 | Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts |
| Q91739608 | The protective effects of silymarin on ischemia-reperfusion injuries: A mechanistic review |
Search more.